Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Reader Login
Users Online :908
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2017| December  | Volume 54 | Issue 5  
    Online since December 29, 2017

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors
A Pathak, S Rajappa, A Gore
December 2017, 54(5):1-8
DOI:10.4103/ijc.IJC_505_17  PMID:29292702
  1,235 516 -
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients
DC Doval, R Deshpande, B Dhabhar, KG Babu, K Prabhash, R Chopra, PV Sripada, C Deshmukh, M Suryavanshi
December 2017, 54(5):25-30
DOI:10.4103/ijc.IJC_514_17  PMID:29292705
  1,227 289 -
Epidermal growth factor receptor mutation testing: From conventional to real-time diagnosis of lung cancer
T Raja, NK Warrier
December 2017, 54(5):9-14
DOI:10.4103/ijc.IJC_507_17  PMID:29292703
  1,182 322 -
Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples
A Chougule, S Basak
December 2017, 54(5):45-54
DOI:10.4103/ijc.IJC_540_17  PMID:29292708
  960 224 -
Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients
U Batra, N Lokeshwar, S Gupta, P Shirsath
December 2017, 54(5):37-44
DOI:10.4103/ijc.IJC_532_17  PMID:29292707
  896 202 -
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
B Biswas, N Ghadyalpatil, MV Krishna, J Deshmukh
December 2017, 54(5):55-64
DOI:10.4103/ijc.IJC_589_17  PMID:29292709
  863 221 -
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinion
Suresh H Advani, Hemant Malhotra, Raju Titus Chacko, Maheboob Basade, Pavithran Keechilat, PN Mahapatra, Chanchal Goswami, TP Sahoo, Chirag Shah
December 2017, 54(5):31-36
DOI:10.4103/ijc.IJC_520_17  PMID:29292706
  675 156 -
Epidermal growth factor receptor T790M mutation: A major culprit in the progression of epidermal growth factor receptor-driven non-small cell lung cancer and the role of repeat biopsy
S Aggarwal, S Patil, N Rohtagi
December 2017, 54(5):15-24
DOI:10.4103/ijc.IJC_510_17  PMID:29292704
  629 174 -
CASE REPORT
Importance of repeat tissue biopsy and tissue-based epidermal growth factor receptor T790M testing in progressed nonsmall cell lung carcinoma patients upon negative plasma genotyping for selection of third-generation tyrosine kinase inhibitor therapy: A case study
R Mistry, A Patil
December 2017, 54(5):65-66
DOI:10.4103/ijc.IJC_545_17  PMID:29292710
  521 149 -
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow